UBS Maintains Neutral on Carter’s, Lowers Price Target to $72
UBS analyst Jay Sole maintains Carter's (NYSE:CRI) with a Neutral and lowers the price target from $100 to $72.
UBS Maintains Buy on Capri Holdings, Lowers Price Target to $65
UBS analyst Jay Sole maintains Capri Holdings (NYSE:CPRI) with a Buy and lowers the price target from $91 to $65.
UBS Maintains Neutral on Boot Barn Holdings, Lowers Price Target to $80
UBS analyst Jay Sole maintains Boot Barn Holdings (NYSE:BOOT) with a Neutral and lowers the price target from $110 to $80.
JP Morgan Maintains Overweight on Whirlpool, Lowers Price Target to $191
JP Morgan analyst Michael Rehaut maintains Whirlpool (NYSE:WHR) with a Overweight and lowers the price target from $227 to $191.
Morgan Stanley Maintains Overweight on Centessa Pharmaceuticals, Lowers Price Target to $10
Morgan Stanley analyst Matthew Harrison maintains Centessa Pharmaceuticals (NASDAQ:CNTA) with a Overweight and lowers the price target from $15 to $10.
Barclays Maintains Overweight on Ferguson, Lowers Price Target to $148
Barclays analyst Matthew Bouley maintains Ferguson (NYSE:FERG) with a Overweight and lowers the price target from $160 to $148.
Morgan Stanley Maintains Equal-Weight on Artivion, Lowers Price Target to $21
Morgan Stanley analyst Cecilia Furlong maintains Artivion (NYSE:AORT) with a Equal-Weight and lowers the price target from $23 to $21.
Morgan Stanley Maintains Overweight on BeiGene, Lowers Price Target to $293
Morgan Stanley analyst Matthew Harrison maintains BeiGene (NASDAQ:BGNE) with a Overweight and lowers the price target from $300 to $293.
Morgan Stanley Maintains Overweight on Becton, Dickinson, Lowers Price Target to $272
Morgan Stanley analyst David Lewis maintains Becton, Dickinson (NYSE:BDX) with a Overweight and lowers the price target from $282 to $272.
Barclays Maintains Overweight on Core & Main, Lowers Price Target to $28
Barclays analyst Matthew Bouley maintains Core & Main (NYSE:CNM) with a Overweight and lowers the price target from $29 to $28.